Guided Therapeutics (GTHP) Non Operating Income (2022 - 2025)
Guided Therapeutics' (GTHP) quarterly Non Operating Income came in at -$48000.0 in Q2 2025, up 11.11% year-over-year from -$43200.0 in Q2 2024, and down 269.23% quarter-over-quarter from -$13000.0 in Q1 2025.
Powered by 
Analysis
Guided Therapeutics (GTHP) Non Operating Income (2022 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Non Operating Income across 4 years of filings, most recently posting -$48000.0 for Q2 2025.
- In Q2 2025, Non Operating Income rose 11.11% year-over-year to -$48000.0; the TTM figure through Jun 2025 stood at -$272000.0 (down 423.08% YoY), while the FY2024 annual figure was -$309000.0, down 865.62% from the prior year.
- Non Operating Income came in at -$48000.0 for Q2 2025 at Guided Therapeutics, down from -$13000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $122000.0 in Q3 2022 to a low of -$859000.0 in Q4 2022.
- Average Non Operating Income over 4 years is -$103692.3, with a median of -$52000.0 recorded in 2023.
- Year-over-year, Non Operating Income jumped 111.53% in 2023 and slumped 219.19% in 2024.
- Over 4 years, Non Operating Income stood at -$859000.0 in 2022, then soared by 111.53% to $99000.0 in 2023, then tumbled by 219.19% to -$118000.0 in 2024, then jumped by 59.32% to -$48000.0 in 2025.
- Per Business Quant data, the three most recent Non Operating Income figures were -$48000.0 in Q2 2025, -$13000.0 in Q1 2025, and -$118000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 46.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | -13,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | -54,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | -52,000.00 |
| Mar 31, 2023 | -26,000.00 |
| Dec 31, 2022 | -859,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | -209,000.00 |